Many Americans Misguided On Daily Aspirin, Survey Finds
By Dennis Thompson HealthDay Reporter
TUESDAY, Feb. 4, 2025 -- Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found.
Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduce the risk of heart attack or stroke outweigh the risks, according to the survey from the Annenberg Public Policy Center of the University of Pennsylvania.
“Habits backed by conventional wisdom and the past advice of health care providers are hard to break,” Kathleen Hall Jamieson, the center's director, said in a news release.
“Knowing whether taking a low-dose aspirin daily is advisable or not for you is vital health information,” she added.
For years, healthy seniors were advised to take low-dose aspirin to reduce heart attack and stroke risk.
The rationale was that aspirin acts as a blood thinner, reducing the risk that a blood clot could cause a heart attack or stroke by clogging an artery.
But in 2019, the leading heart groups -- the American College of Cardiology and the American Heart Association -- reversed that recommendation in a set of new guidelines.
The groups concluded that daily aspirin for healthy seniors 70 and older wasn’t worth the risk of gastrointestinal bleeding.
"If you’re over 70, taking aspirin to prevent a first heart attack or stroke could do more harm than good," the AHA now says on its website.
Aspirin still is recommended for people with diagnosed heart disease who don’t have an increased risk of bleeding.
This updated guidance has failed to break through decades of advice supporting daily low-dose aspirin, the poll found.
Nearly 1 in 5 U.S. adults who have no personal or family history of heart problems report routinely taking low-dose aspirin. According to survey results:
10% say they take it “basically every day.”
6% take it “a few times a month.”
2% take it “a few times a week.”
Younger adults were more likely than older folks to correctly report that the risks of aspirin outweigh the benefits, the survey showed.
About 29% of 18- to 29-year-olds with no personal or family history of heart disease correctly said the risks of daily aspirin outweigh benefits, compared with 11% of those 40 to 59 and 7% of those 60 and older, researchers found.
That’s likely because the younger folks haven’t been exposed as much to the outdated guidance supporting aspirin use, researchers said.
The survey involved 1,771 people polled Nov. 14 to 24, 2024, and has a margin of error of plus or minus 3.3 percentage points.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-05 00:00
Read more
- Ketamine Use Is on the Rise in U.S.
- Trump-Era HHS Website Makes Term ‘Abortion’ Harder To Find
- Long COVID Severity Linked to White Blood Cell Count
- Recent Decades Saw Rise in Sedative, Hypnotic, Anxiolytic Use Disorders
- Enhertu Approved as First HER2-Directed Therapy for Patients with HER2-Low or HER2-Ultralow Metastatic Breast Cancer
- Sports Boost Academic Performance in Teens
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions